• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W. L. GORE & ASSOCIATES, INC. GORE® DRYSEAL FLEX INTRODUCER SHEATH; INTRODUCER, CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W. L. GORE & ASSOCIATES, INC. GORE® DRYSEAL FLEX INTRODUCER SHEATH; INTRODUCER, CATHETER Back to Search Results
Model Number DSF2233
Device Problem Improper or Incorrect Procedure or Method (2017)
Patient Problem Perforation of Vessels (2135)
Event Date 11/25/2021
Event Type  Injury  
Manufacturer Narrative
(b)(4).It should be noted the gore® dryseal flex introducer sheath instructions for use (ifu) state ¿adequate vessel access is required to introduce the sheath into the vasculature.Careful evaluation of vessel size, anatomy, tortuosity, and disease state (including calcification, plaque, and thrombus) is required to ensure successful sheath introduction and subsequent withdrawal.If vessel is not adequate for access, major bleeding, vessel damage, or serious injury to the patient, including death, may result.¿ additionally, per ifu, if vessel size is smaller than the nominal body outer diameter, major bleeding, vessel damage, or serious injury to the patient, including death, may result.
 
Event Description
On (b)(6) 2021, the patient underwent endovascular treatment of a thoracic aneurysm using a 22fr gore® dryseal flex introducer sheath (nominal body outer diameter: 8.2mm) as an accessory during the procedure.The right access vessel measured a reported 6-7 mm in diameter, and there reportedly was stenosis in the right external iliac artery.Percutaneous transluminal angioplasty was performed with an 8 mm balloon before sheath insertion.During insertion of the 22fr sheath, resistance was reportedly felt at the right external iliac artery.The sheath was removed once and reinserted successfully.After stent graft implantation, access angiography reportedly showed vessel damage in the right external iliac artery.Two additional stent grafts were implanted to treat the damaged vessel.According to the report, a dissection was also observed in the common iliac artery (no further details regarding the dissection were available).The physician opted to take a wait-and-watch approach regarding the dissection, and the procedure was completed.The patient tolerated the procedure.
 
Manufacturer Narrative
Added g3/g4 with pma/510k number added h1/h2 and h6 conclusion code.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE® DRYSEAL FLEX INTRODUCER SHEATH
Type of Device
INTRODUCER, CATHETER
Manufacturer (Section D)
W. L. GORE & ASSOCIATES, INC.
1505 n. fourth street
flagstaff AZ 86004
Manufacturer (Section G)
MEDICAL PHOENIX 1 B/P
32360 n. north valley parkway
phoenix AZ 85085
Manufacturer Contact
damon jackson
1505 n. fourth street
flagstaff, AZ 86004
9285263030
MDR Report Key12961356
MDR Text Key281923971
Report Number3007284313-2021-01697
Device Sequence Number1
Product Code DYB
UDI-Device Identifier00733132630073
UDI-Public00733132630073
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
K160254
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 05/02/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/08/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberDSF2233
Device Catalogue NumberDSF2233
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received05/02/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured07/06/2021
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention; Hospitalization;
Patient Age81 YR
Patient SexFemale
-
-